Summary
This study examined dosage prescribing patterns and steady-state oxipurinol plasma concentrations in 66 patients receiving chronic allopurinol therapy. Most patients (65%) were taking 300 mg allopurinol daily, although renal impairment was common.
Using published guidelines, it was estimated that 35% of patients were receiving excessive dosages of allopurinol. Consequently, the plasma oxipurinol concentrations were often very high (mean (SD) was 156 (109) μmol·1−1). Accumulation of oxipurinol was inversely related to renal function. Plasma concentrations of oxipurinol and urate were not significantly related. However, most patients with oxipurinol concentrations of up to 100 μmol·1−1 had urate concentrations within the normal reference range.
References
Hande KR, Noone RM, Stone WJ (1984) Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 76: 47–56
Singer JZ, Wallace SL (1986) The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 29: 82–87
Cameron JS, Simmonds HA (1987) Use and abuse of allopurinol. Br Med J 294: 1504–1505
Murrell GAC, Rapeport WG (1986) Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet 11: 343–353
Emmerson BT, Gordon RB, Cross M, Thomson DB (1987) Plasma oxipurinol concentrations during allopurinol therapy. Br J Rheumatol 26: 445–449
Boulieu R, Bory C, Baltassat P, Gonnet C (1984) Simultaneous determination of allopurinol, oxipurinol, hypoxanthine and xanthine in biological fluids by high-performance liquid chromatography. J Chromatogr 307: 469–474
Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31–41
Day RO, Miners JO, Birkett DJ et al. (1988) Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion. Br J Clin Pharmacol 26: 423–428
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peterson, G.M., Boyle, R.R., Francis, H.W. et al. Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy. Eur J Clin Pharmacol 39, 419–421 (1990). https://doi.org/10.1007/BF00315424
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315424